ZAKRZEWSKI JOSEPH S sold 22.5% of their position (10K shares) of ACCELERON PHARMA INC on the open market
Open‑market sale worth $1.41M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/5/2021ACC: 0001179110-21-004227
-10K
Net shares
Net seller
$1.41M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+10K
Price / share
$24.11
Trade value
$241.10K
% of position
29.0%
4/5/2021
34.50K→44.50K
Common Stock
Direct
Shares
−6.75K
Price / share
$140.31
Trade value
$946.81K
% of position
15.2%
4/5/2021
44.50K→37.75K
Common Stock
Direct
Shares
−2.15K
Price / share
$141.28
Trade value
$304.03K
% of position
5.7%
4/5/2021
37.75K→35.60K
Common Stock
Direct
Shares
−1.10K
Price / share
$142.27
Trade value
$156.50K
% of position
3.1%
4/5/2021
35.60K→34.50K
Total
Net shares
+0.00
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/5/2021 | M · Option Exercise | +10K | $24.11 | $241.10K | 29.0% | 34.50K | 44.50K |
| Common Stock Direct | 4/5/2021 | S · Sale | −6.75K | $140.31 | $946.81K | 15.2% | 44.50K | 37.75K |
| Common Stock Direct | 4/5/2021 | S · Sale | −2.15K | $141.28 | $304.03K | 5.7% | 37.75K | 35.60K |
| Common Stock Direct | 4/5/2021 | S · Sale | −1.10K | $142.27 | $156.50K | 3.1% | 35.60K | 34.50K |
| Total | +0.00 | -$1.17M | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
24.11
Held after
0.00
Exercisable
—
4/5/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock10K shares | 4/5/2021 | M · Option Exercise | −10K | 24.11 | — | 0.00 |